Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Relapsing-remitting Multiple Sclerosis (RRMS)
Kansas City, Kansas
Relapsing-remitting Multiple Sclerosis (RRMS) Clinical Trials in Kansas City, Kansas
1 recruiting
Kansas City, Kansas
Showing
1–1
of
1
trials
Recruiting
Phase 3
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen
444 enrolled
107 locations
NCT06700343
Feedback